INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo PULMAX 400 MDI

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
no data

PROPRIETARY NAME
(and dosage form):

PULMAX 400 MDI
dry powder for inhalation

COMPOSITION:
Each actuation contains
budesonide 400.0 micrograms

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
37/21.5.1/0015

APPLICANT:
BIOTECH LABORATORIES (PTY) LTD
http://www.biotech.co.za/

MANUFACTURER:
NORTON (WATERFORD) LIMITED, WATERFORD, IRELAND

AVAILABILITY:
no data

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette -
STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Date posted: July 2014
For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014